Peptide Therapy: What's Proven, What's Hype, and How to Start Safely

Key takeaways

• Peptide therapy uses short chains of amino acids to signal specific processes in the body.
• The best-studied peptides for weight loss are FDA-approved medications, such as those based on glucagon-like peptide-1 (GLP-1), backed by large human trials.
• Many wellness peptides, like BPC-157, rely mostly on animal and lab research, and their legal status is still in flux in 2026.
• Products sold "for research use only" online carry real risks around contamination, sourcing, and dosing.
• A licensed clinician can help decide whether a peptide medication fits into a broader weight care plan.

Peptide therapy uses peptides—short chains of amino acids—as treatments that signal specific processes, like blood sugar control, appetite, or tissue repair. The marketing around it is much messier.

Peptides now show up on med spa menus and across social feeds, often pitched as anti-aging or recovery "breakthroughs." Some peptide therapies are among the most rigorously studied treatments in medicine, while others have little human evidence behind them. The word "peptide" alone doesn't tell you which is which.

The wellness industry blurs that line. Clinicians can't afford to. This guide covers how to tell the difference, what's legal right now, what peptide therapy costs, and how to start safely.

What is peptide therapy?

Peptides are short chains of amino acids, typically two to 50, linked by chemical bonds, according to the National Human Genome Research Institute [1]. Longer chains are polypeptides and proteins.

Many peptides act as messengers. They bind to receptors on cells and trigger a specific response. The GLP-1 hormone, for example, helps regulate blood sugar levels and control appetite.

Peptide therapy means using natural or lab-made peptides as treatment. Most people picture peptide injections, but some peptides come as an oral tablet, a nasal spray, or a topical product.

None of this is new. Insulin is a peptide therapy, and it was first used to treat a patient in 1922 [2][3]. By 2021, more than 80 peptide medications had reached the market worldwide, according to a review in Nature Reviews Drug Discovery [4].

Found's guide to what peptides are covers the deeper biology, and the peptides-to-watch roundup covers individual compounds. This article tackles a different question: whether peptide therapy makes sense as a treatment decision.

Is Ozempic a peptide therapy?

Yes. Semaglutide, the active ingredient in Ozempic® and Wegovy®, is a lab-made version of the GLP-1 peptide hormone, designed to last longer in the body [5]. Harvard Health Publishing counts GLP-1 medications among peptide treatments [6].

Tirzepatide, the active ingredient in Zepbound® and Mounjaro®, is also peptide-based. It's a dual agonist, meaning it activates receptors for two hormones: GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) [7]. These medications are the clearest benchmark for what proven peptide therapy looks like.

In the STEP 1 trial, published in the New England Journal of Medicine in 2021, adults without diabetes took semaglutide 2.4 mg weekly. They lost an average of 14.9% of body weight at 68 weeks, compared with 2.4% on placebo. Both groups also received a lifestyle intervention [8].

SURMOUNT-1, published in the same journal in 2022, tested tirzepatide in adults without diabetes, also alongside lifestyle intervention. Weight loss averaged up to 20.9% at 72 weeks on the highest dose (15 mg), compared with 3.1% on placebo [9]. These are averages from manufacturer-funded trials, and individual results vary.

On December 22, 2025, Novo Nordisk announced FDA approval of the Wegovy pill, the first oral GLP-1 approved for weight management [10]. Found isn't affiliated with Novo Nordisk or Eli Lilly and Company.

The three tiers of peptide therapy

Every peptide offer falls into one of three tiers, and the tier tells you more than any marketing claim.

The same word, "peptide," covers all three tiers. Marketing often borrows Tier 1's credibility to sell Tier 3. A clinic might list GLP-1 trial results beside a BPC-157 "recovery protocol," though the evidence is worlds apart.

If you're searching for the best peptides for weight loss, Tier 1 is where the evidence lives. Tier 2 calls for real caution. The FDA states that compounded medications aren't FDA-approved, so the agency doesn't review them for safety, effectiveness, or quality before they're sold [11].

That's why quality in Tier 2 depends on pharmacy licensing, clinician oversight, and sourcing checks. The FDA also states that compounded versions are meant only for patients whose medical needs can't be met by an FDA-approved medication [11]. Found clinicians prescribe Tier 1 medications and, when clinically appropriate, compounded options from licensed pharmacies.

Compounded GLP-1s aren't reviewed by the FDA for safety or efficacy and aren't approved to treat specific conditions [11]. Prescriptions are provided only if clinically appropriate after a medical evaluation.

Tier 3 peptides are often sold as "natural." Natural doesn't mean risk-free, and it tells you nothing about whether a product is pure, correctly dosed, or tested in people. Peptides sold like supplements aren't a replacement for medical care.

Does peptide therapy work? What the evidence shows

It depends on the peptide and the goal. The strongest human evidence covers weight and metabolic health (GLP-1 and dual agonist medications), blood sugar (insulin), and other approved uses. Anthony C. Tam, MD, of Henry Ford Health, told the American Medical Association (AMA) that insulin and GLP-1s are "very well studied." [12]

The evidence thins out fast for tissue repair and recovery (BPC-157, TB-500), growth hormone–boosting peptides for body composition, and claims about cognition, sleep, and anti-aging. Harvard Health's July 2026 review found that "evidence for such benefits in people is largely absent." [6] The FDA has noted limited safety data on BPC-157 and no human-exposure data on TB-500 [13].

Most of the research comes from animal models. Dr. Tam pointed to one human study of about 10 to 12 people with knee pain, with limited details. "There's nothing substantial to show these results would translate to humans," Dr. Tam said [12].

A promising rat study isn't proof for people. Before trusting any peptide therapy benefits, ask whether it was tested in humans, in how many people, and for how long.

A recent review in Acta Diabetologica looked at body-composition substudies of STEP 1 and SURMOUNT-1. Roughly a quarter to a third of the weight lost was lean mass, which the authors note is similar to diet-induced weight loss. The authors note that the best strategies to protect muscle during treatment still need more study [14].

Protein and strength training are commonly recommended, and Found's guide to GLP-1s and muscle loss goes deeper. It's one reason medication is the icing on the cake, not the cake. Lasting weight care pairs it with nutrition, movement, sleep, and support.

Is peptide therapy legal? Where the FDA stands in 2026

FDA-approved peptide medications are legal with a prescription. Wellness peptides are messier, and their FDA status has shifted several times since 2023.

Before 2026, BPC-157, TB-500, and several other popular peptides sat in Category 2 of its 503A compounding list, the FDA's category for substances that may present significant safety risks [13].

In April 2026, the FDA moved several peptides, including BPC-157 and TB-500, out of Category 2 because their nominations were withdrawn [13]. That wasn't a safety finding. The FDA's own page still describes the same unknowns [13].

In July 2026, an FDA advisory committee [15] narrowly voted to recommend letting pharmacies compound some peptides, including BPC-157 and TB-500 [16][17]. FDA staff had recommended against it, according to The American Journal of Managed Care [17]. Advisory committee votes are non-binding, and the FDA makes the final decision [15][16].

As of July 31, 2026, The American Journal of Managed Care reported that none of these peptides had been added to the FDA's approved compounding list [17]. This is changing, so check the FDA's current list. Changing that list requires a formal notice-and-comment process. "Not banned" isn't the same as "approved" or "proven safe."

Products labeled "for research use only" or "not for human consumption" aren't legal medicine, and they aren't held to pharmaceutical manufacturing standards. The FDA has warned companies selling GLP-1 products falsely labeled "for research purposes." [11]

Is peptide therapy safe? Side effects and red flags

Peptide therapy side effects depend on the peptide. With GLP-1 medications, Dr. Tam told the AMA that "sometimes people feel nauseous or experience an upset stomach, diarrhea or constipation." [12] He also noted a possible risk of pancreatitis [12], one reason clinician monitoring matters.

Reported side effects of newer peptides include injection-site irritation, fatigue, headache, and digestive issues, though much remains unknown, according to the AMA [12].

With Tier 3, the biggest risk is what's actually in the vial. Harvard Health notes that unregulated peptides "may be contaminated with impurities, according to the FDA." [6] Oversight gaps show up in Tier 2 as well.

As of May 31, 2026, the FDA had received 990 adverse-event reports for compounded semaglutide and more than 730 for compounded tirzepatide [11]. Reports don't prove a product caused harm, and the FDA notes they're likely underreported. Some involved dosing errors that required hospitalization [11].

Red flags to watch for:

• No medical evaluation before a prescription
• "Research use only" or "not for human consumption" labels
• No named, state-licensed pharmacy
• Promises of fast or guaranteed results
• Pricing that seems too good to be true
• No plan for follow-up or monitoring

Some people should review risks with a clinician before starting any peptide medication. That includes anyone who is pregnant or trying to conceive, has a history of pancreatitis, or has a personal or family history of medullary thyroid cancer [5][7].

Found clinicians follow a "start low, go slow" approach, increasing doses gradually to help minimize side effects. For people who want an even more gradual path, Found's microdosing program offers clinician-guided, lower-dose GLP-1 care.

How much does peptide therapy cost?

Wellness peptide protocols vary in price from clinic to clinic, so ask for a written quote and ask directly whether insurance applies. There's no reliable public data on typical peptide therapy cost for these protocols.

FDA-approved peptide medications for weight may be covered, but coverage varies widely. In KFF's 2025 Employer Health Benefits Survey, 19% of firms with 200 or more workers covered GLP-1 medications for weight loss in their largest plan. Among firms with 5,000 or more workers, that figure was 43% [18].

Some manufacturers offer self-pay programs, and they set prices and eligibility that can change.

Ask for the total cost: visits, medication, labs, and follow-up. To find out whether peptide therapy is covered by insurance for you, Found's free GLP-1 Coverage Checker contacts your insurer directly. You'll get a personalized coverage summary with estimated costs before deciding on treatment.

Found combines insurance-covered medical care with access to affordable cash-pay GLP-1 options. Insurance coverage varies and isn't guaranteed.

How to start peptide therapy safely

Start with your goal before choosing a peptide. About 4 in 10 US adults (40.3%) have obesity, according to CDC data from 2021–2023 [19][20]. Weight and metabolic health also have the strongest peptide options.

Next, choose a licensed clinician who reviews your health history and labs before prescribing. A search for "peptide therapy near me" often turns up med spas, but the clinician's training matters more than distance. Peptide therapy online through telehealth can be a convenient option.

Ask five questions:

1. Is this FDA-approved?
2. If it's compounded, which licensed pharmacy makes it?
3. What human evidence supports it?
4. How will you monitor me?
5. What's the total cost?

Expect a plan that pairs medication, if appropriate, with nutrition, movement, sleep, and support. Women in perimenopause or with polycystic ovary syndrome (PCOS) may benefit from discussing metabolic changes with a clinician early.

Found's doctor-designed program builds a personalized plan from a metabolic assessment, with virtual access to licensed clinicians. Prescriptions are provided only if clinically appropriate.

Frequently asked questions

Is peptide therapy good for weight loss?

FDA-approved peptide medications have strong trial evidence for weight loss, and they may work best as long-term treatment within a broader plan. Wellness peptides marketed for fat loss don't have comparable human evidence.

Do peptide injections really work?

Some do, but the evidence behind the ingredient matters far more than the delivery method. Semaglutide, for example, now also comes as a daily oral tablet [5].

How long does it take to see results from peptide therapy?

Timelines vary by person and medication. In the major weight trials, doses were increased gradually over several months, and results were measured at 68–72 weeks [8][9].

Are peptides the same as steroids?

No—peptides are chains of amino acids, while steroids are a different group of molecules, a class of lipids (fats) [21]. A different label still doesn't mean lower risk.

Can I buy peptides online?

You can get FDA-approved peptide medications online through a licensed telehealth clinician and pharmacy. If a site lets you check out before any medical evaluation, treat that as a warning sign.

Is peptide therapy covered by insurance?

It depends on your plan and the medication. KFF found that 34% of large employers covering GLP-1s for weight require a lifestyle program or dietitian [18].

Start with what your body needs

Curiosity about peptides often comes back to a simpler question: What does your body actually need? Found's doctor-led weight care starts there, with a metabolic assessment and a licensed clinician. Your personalized plan may include medication, if it's clinically appropriate, alongside nutrition, movement, sleep, and support.

Ready to explore what that could look like? Get started

Individual results may vary.

Sources

1. National Human Genome Research Institute: Peptide (Talking Glossary of Genomic and Genetic Terms)
2. Fralick M, Zinman B. The discovery of insulin in Toronto: beginning a 100 year journey of research and clinical achievement. Diabetologia, 2021
3. University of Toronto: Discovery of Insulin at University of Toronto (Heritage U of T)
4. Muttenthaler M, et al. Trends in peptide drug discovery. Nature Reviews Drug Discovery, 2021
5. FDA: Wegovy (semaglutide) injection and tablets prescribing information, revised June 2026
6. Harvard Health Publishing: Peptides: What they are, potential benefits, and safety concerns, July 2026
7. FDA: Zepbound (tirzepatide) injection prescribing information, revised August 2026
8. Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine, 2021
9. Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine, 2022
10. Novo Nordisk: Company announcement on FDA approval of the Wegovy pill, December 22, 2025
11. FDA: FDA's concerns with unapproved GLP-1 drugs used for weight loss
12. American Medical Association: What doctors want patients to know about injectable peptides, April 2026
13. FDA: Certain bulk drug substances for use in compounding that may present significant safety risks
14. Rossi et al. Muscle loss and GLP-1R agonists use. Acta Diabetologica, published online November 2025
15. FDA: July 23–24, 2026, meeting of the Pharmacy Compounding Advisory Committee
16. ABC News: FDA advisory committee vote on the peptide BPC-157, July 23, 2026
17. The American Journal of Managed Care: FDA panel backs 6 peptides for compounding
18. KFF: 2025 Employer Health Benefits Survey
19. CDC National Center for Health Statistics: Data Brief 508, obesity and severe obesity prevalence in adults, August 2021–August 2023
20. CDC National Center for Health Statistics: Health E-Stat 111, prevalence of overweight, obesity, and severe obesity among adults, February 2026
21. National Cancer Institute: Steroid (NCI Dictionary of Cancer Terms)